Examining the effectiveness of telemonitoring with routinely acquired blood pressure data in primary care: challenges in the statistical analysis by Parker, Richard A. et al.
RESEARCH ARTICLE Open Access
Examining the effectiveness of
telemonitoring with routinely acquired
blood pressure data in primary care:
challenges in the statistical analysis
Richard A. Parker1* , Paul Padfield1, Janet Hanley2, Hilary Pinnock1, John Kennedy3, Andrew Stoddart1,
Vicky Hammersley1, Aziz Sheikh1 and Brian McKinstry1
Abstract
Background: Scale-up BP was a quasi-experimental implementation study, following a successful randomised
controlled trial of the roll-out of telemonitoring in primary care across Lothian, Scotland. Our primary objective was
to assess the effect of telemonitoring on blood pressure (BP) control using routinely collected data. Telemonitored
systolic and diastolic BP were compared with surgery BP measurements from patients not using telemonitoring
(comparator patients). The statistical analysis and interpretation of findings was challenging due to the broad range
of biases potentially influencing the results, including differences in the frequency of readings, ‘white coat effect’,
end digit preference, and missing data.
Methods: Four different statistical methods were employed in order to minimise the impact of these biases on the
comparison between telemonitoring and comparator groups. These methods were “standardisation with
stratification”, “standardisation with matching”, “regression adjustment for propensity score” and “random coefficient
modelling”. The first three methods standardised the groups so that all participants provided exactly two
measurements at baseline and 6–12 months follow-up prior to analysis. The fourth analysis used linear mixed
modelling based on all available data.
Results: The standardisation with stratification analysis showed a significantly lower systolic BP in telemonitoring
patients at 6–12 months follow-up (-4.06, 95% CI -6.30 to -1.82, p < 0.001) for patients with systolic BP below 135 at
baseline. For the standardisation with matching and regression adjustment for propensity score analyses, systolic BP
was significantly lower overall (− 5.96, 95% CI -8.36 to − 3.55 , p < 0.001) and (− 3.73, 95% CI− 5.34 to − 2.13, p < 0.001)
respectively, even after assuming that − 5 of the difference was due to ‘white coat effect’. For the random coefficient
modelling, the improvement in systolic BP was estimated to be -3.37 (95% CI -5.41 to -1.33 , p < 0.001) after 1 year.
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Conclusions: The four analyses provide additional evidence for the effectiveness of telemonitoring in controlling BP in
routine primary care. The random coefficient analysis is particularly recommended due to its ability to utilise all
available data. However, adjusting for the complex array of biases was difficult. Researchers should appreciate the
potential for bias in implementation studies and seek to acquire a detailed understanding of the study context in order
to design appropriate analytical approaches.
Keywords: Routine data, Implementation study, Quasi-experimental, Telemonitoring, Blood pressure control,
Hypertension, End digit preference
Background
Implementation studies enable the evaluation of research
interventions in a real-world context, for example, in
routine primary care. When combined with the collec-
tion of longitudinal data from electronic health records
or data which are otherwise routinely acquired, these
evaluation studies are not only data rich in terms of the
information they provide, but are often based on patient
populations that are highly generalisable and representa-
tive of the target population [1, 2]. Such studies provide
great opportunities, but also great challenges, many of
which are outlined in this paper.
Since 2015, in Lothian (south east Scotland), the
Scale-Up BP implementation project has been using
telemonitoring to monitor blood pressure (BP) in people
with previously diagnosed hypertension. The telemoni-
toring system was designed based on the findings of the
Health Impact of nurse-led Telemetry Services (HITS)
randomised controlled trial [3] and subsequent research
to explore barriers to implementation [4]. Participants
used an electronic oscillometric sphygmomanometer to
measure BP and then submitted BP readings via their
own mobile phone using a low-cost third-party text-
based telemonitoring system procured by the Scottish
Government (Florence) [5]. These patient-generated BP
readings were stored in a central server and made
available to practices via an Internet link. Summaries of
BP data were then displayed in the primary care data
management system, Docman, at intervals chosen by the
clinicians. Patients were informed by automated text
responses if submitted readings were low, normal, high,
or very high and were advised to follow a written action
plan with respect to contacting their practice either
routinely or urgently as appropriate. Full details about
the system and the overall Scale-up BP project are provided
elsewhere [6]. The Scottish Government’s Technology
Enabled Care (TEC) fund [7] financed the third-party
telemonitoring service, the development of the software to
link it with GP systems using Docman, supported facilita-
tors to visit/train practices, and purchased sphygmoma-
nometers for loan to patients.
Although randomised controlled trials [8] have shown
the effectiveness of telemonitoring in monitoring BP, the
effectiveness and impact when the system is provided as a
routine approach to care in general practice is uncertain.
The Scale-up BP evaluation study aimed to use routinely
acquired data and outcomes (including BP readings)
extracted from GP records to evaluate the impact and
acceptability of telemonitoring in this population.
Eight practices were purposely chosen to be repre-
sentative of all practices in Lothian such that they
represented a range of sizes, levels of deprivation,
and length of time since first adopting the system.
Systolic and diastolic BP values from patients in the
eight practices who used the telemonitoring system
were then compared with BP values from patients
who did not use the telemonitoring system from the
same practices. The results of this evaluation study
are published elsewhere [6], but in that paper we did
not include a detailed comparison of BP between
intervention and comparator groups.
In this article we present the results of an in-depth
analysis employing a range of methods to investigate if
telemonitoring improves BP control when routinely
implemented at scale, while illustrating some of the
challenges involved with evaluating effectiveness in a
quasi-experimental study involving routinely acquired
data.
Comparison of surgery readings with home telemoni-
tored readings was challenging in this context for eight
main reasons which are outlined in Table 1.
We attempted to address as many of these issues as
possible in our analysis by using four different approaches
that are compared in this setting: (i) standardisation with
stratification, (ii) standardisation with matching, (iii) regres-
sion adjustment for propensity score, and (iv) mixed-effects
modelling. The issues faced and the methods we used to




Some processing of the raw BP data was necessary
before analysis could proceed to exclude any errone-
ous observations. We applied the following exclusion
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criteria (which were the same as those used in our
previous end digit preference study [10]):
 Systolic BP less than 60mmHg
 Systolic BP greater than 262 mmHg
 Diastolic BP less than 40 mmHg
 Diastolic BP greater than 124 mmHg
 Diastolic BP greater than systolic BP
 Systolic BP less than 10mmHg higher than diastolic
Patients who did not use the telemonitoring system were
identified as comparator patients. To make the comparator
patients as similar as possible to the telemonitoring pa-
tients, we only included patients between 18 and 90 years
old, and excluded any surgery BP readings measured before
telemonitoring was introduced in Lothian (1st Sept 2015).
End digit preference
There is widespread evidence for end digit preference in
BP measured by clinicians in the surgery or by patients
at home using manual telemonitoring systems [10–13].
It is therefore recognised as an important source of
potential bias in BP records. Although the occurrence
and magnitude of end digit preference among the tele-
monitoring patients included in this study has already
been thoroughly evaluated in another paper [10], we
were uncertain about the magnitude of end digit prefer-
ence in surgery measured BP values among comparator
patients. We therefore sought to evaluate the extent of
end digit preference in the comparator group and com-
pare this with the results from our previous paper based
on the telemonitored BP [10]. This involved using bar
charts of end digits and a simple cross tabulation of
systolic BP end digits against diastolic BP end digits to
determine end digit frequencies and the prevalence of
double-zero digit preference (i.e. both systolic BP and
diastolic BP end with a zero). No formal hypothesis test-
ing was performed because strongly significant p-values
were highly likely due to the very large sample size.
Standardisation with stratification
Differences in the frequency of readings between tele-
monitoring and comparator groups led us to try to
standardise the comparison of “before” and “after” when
analysing the change in BP readings over time. The
Table 1 Description of the challenges and potential biases faced in this study
(1) Non-randomised design Patients were not randomised as this was a scheduled implementation of an evidence-based intervention [6].
In some practices almost all patients on the practice hypertension register were offered the intervention, but
other practices adapted the implementation strategies to concentrate initially on various sub-groups e.g.
patients with poorly controlled hypertension; those of working age who were more likely to find surgery visits
difficult; low risk patients; or those assessed as being more able to manage the system. As a result, the non-
participating patients (comparator group) were systematically different at baseline from those in the
telemonitoring group.
(2) White coat effect Surgery readings were likely to be affected by ‘white coat effect’ [9], whereby BP tends to be higher in clinical
settings compared to home settings. This causes confounding bias when seeking to determine the difference
between readings taken by the telemonitoring group at home and readings taken in the comparator group in
the surgery.
(3) High variability in the
frequency of readings
Surgery readings were often recorded much less frequently than home readings, raising the possibility of a
type of ascertainment bias whereby raising or lowering of BP is much more easily identified for those in the
telemonitoring group. This is related to the problem highlighted by Goldstein (2020) whereby data may be
collected at different rates or not at all, and therefore any missing data may be informative of underlying
health status [1]. Patients in the Scale-up BP study were on different protocols for how frequently they should
measure their BP and (probably for clinical reasons) these varied over time. For example: less frequent protocols
would be required when BP is stable than when adjusting treatment to improve control. Adherence may also
have varied over time.
(4) Contamination of readings We observed that home readings are sometimes transcribed by general practitioners into practice systems
which are thus indistinguishable from surgery readings, [6] making comparison of apparent surgery readings
prone to error. Although this was likely to have occurred more frequently in the telemonitoring group, it could
also have occurred in the comparator group (e.g. if comparator patients had access to home reading systems).
In any case, this would have had the effect of diluting the intervention effect.
(5) Regression to the mean Reductions in BP over time were likely to be affected by regression-to-the mean in both groups, but particularly
in the telemonitoring group as patients were prospectively selected for telemonitoring (perhaps based on their
level of BP control).
(6) Measurement error Individual BP readings will be measured with measurement error such that they may deviate from their true
value. This is expected to increase the overall variability of BP measurements.
(7) End digit preference We had discovered that a limited level of end digit bias was present in home telemonitored readings [10],
however we were unsure as to how large this effect would be in surgery based readings.
(8) Withdrawal bias A small proportion of patients (7%) dropped out of the telemonitoring arm, and there were missing data across
both groups. We found that telemonitoring patients with higher starting systolic BP were more likely to drop
out [6]. The reason for this is unknown.
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frequency of readings was also highly variable within
each group. We therefore calculated the change in BP
values between baseline and a second reading 6–12
months later for all patients, where the second reading
was taken to be as close as possible to 12months if there
was choice between multiple readings. For simplicity, we
refer to this second reading 6–12months later as a “final
reading”. In the telemonitoring group; “baseline” was
taken to be the second reading after the patient started
using the telemonitoring system due to a concern that
the first reading may have been used to test the system.
For the comparator patients, they did not (to our know-
ledge) use the telemonitoring system and so it was im-
portant that we avoided using historical BP readings
taken before the telemonitoring system was rolled out in
Lothian to reduce the possibility of secular time-related
biases. To that end, we only used “baseline” BP readings
from comparator patients taken after 1st September
2015, the start of telemonitoring. Also, we only included
patients with a full year of follow-up (e.g. those only
recently recruited to telemonitoring were excluded). In
the comparator group, any patients with age recorded as
being under 18 or over 90 years old at the start of the
telemonitoring service were excluded to make the groups
as comparable as possible since no children or extremely
elderly patients were recruited to use telemonitoring.
Descriptive statistics were calculated for the BP differ-
ences overall and stratified by important pre-specified
subgroups. These were sex (male/female), age (< 65/65+
), index systolic BP, and Scottish Index of Multiple
Deprivation (SIMD) 2012 decile (< 5 / 5+) [14]. (For
SIMD, lower values indicate a higher level of deprivation
[14].) Stratification was important in this population, as
the groups may have differed according to sociodemo-
graphic characteristics.
BP differences were calculated as baseline minus final
reading. These differences were then compared between
telemonitoring and comparator groups by fitting linear
mixed effects models to the data, with BP difference as
the outcome variable, and adjusting for SIMD (< 5 ver-
sus 5+), gender, and age. We then stratified according to
systolic BP, rather than including this variable in the
model, to avoid any bias due to modelling the relation-
ship between change and initial value in regression
models [15]. GP practice was included in the models as
a random effect.
The percentage of patients with raised systolic and dia-
stolic BP at baseline and follow-up (final reading 6–12
months later) were calculated for various thresholds in-
dicating raised BP (135 +mmHg, 140 +mmHg, 145 +
mmHg, and 150 +mmHg for systolic BP; 85 +mmHg
and 90 +mmHg for diastolic BP) with percentage rela-
tive risk reductions presented for the change in BP over
time in the telemonitoring and comparator groups. For
the 145 +mmHg threshold comparison, we illustrate the
use of a “relative risk reduction ratio” to compare be-
tween groups, with approximate bootstrap 95% confi-
dence intervals calculated using the non-parametric
bootstrap based on 9999 resamples.
Standardisation with matched cohort analysis
Baseline and final BP values were calculated as for the
stratified analysis. Telemonitoring patients were matched
against comparator patients in a 1:1 ratio according to:
(i) exact SIMD, (ii) gender, (iii) age by decade (e.g. 50s,
60s), and (iv) first systolic BP for comparator patients
(and second systolic BP for telemonitoring patients) to
the nearest value ending in 0 or 5 (e.g. systolic BP 130,
135, 140).
All surgery measurements from comparator patients
(systolic BP and diastolic BP) were reduced by − 5 prior
to analysis to take into account the expected ‘white coat
effect’ and to attempt to make them more comparable
with comparator patients. This difference is supported
by the National Institute for Health and Care Excellence
(NICE) guidelines for the diagnosis of hypertension [9].
Nevertheless, we tested this assumption in sensitivity
analyses below.
After matching, final systolic and diastolic BP
values were compared between the telemonitoring
and comparator groups using a paired t-test. Only
final values in the time window between six and 12
months after the index baseline BP reading were
considered. As in the stratified analysis, no BP mea-
surements prior to September 2015 were included.
We also ensured that only independent matched
pairs of patients were included in the analysis. If
more than one comparator patient could be matched
with a telemonitoring patient, then the comparator
patient with BP measurements closest in time to the
telemonitoring measurement was selected.
Practice effect was not adjusted for in the models:
when we tried to adjust for practice effect as a random
variable, the estimate of the variance was zero.
Regression adjustment for propensity score
Propensity score methods aim to summarise a list of
confounders into a single score where each propensity
score represents the probability of group membership
(intervention/control) for each subject based on a list of
confounders. We applied a “regression adjustment for
the propensity score” method [16] to the same standard-
ized dataset as used in the previous two methods. An ad-
vantage of this method is that it still enables unbiased
estimation of treatment effects in linear models condi-
tional on confounders if only the propensity score model
is correctly specified and not necessarily the outcome re-
gression model [16].
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To derive the propensity score, we first fitted a simple
logistic regression model to the group variable (telemoni-
toring versus control), with SIMD 5+, female gender,
patient age, and systolic BP at baseline as covariates. This
model generated predicted values for group measurement
for all individuals which served as the propensity scores.
These propensity scores were then adjusted for in a
separate linear mixed effects regression model fitted to
final systolic BP with intervention group as an explanatory
variable and conditioned on propensity score. GP practice
was included as a random effect in the models.
Random coefficient modelling
A random coefficients model (mixed effects analysis) was
used to analyse the BP data for each practice and overall.
Only BP outcome data collected after 1st September 2015
were included in the analysis, except that we adjusted for
the number of surgery BP measurements prior to the start
of telemonitoring (or prior to first surgery BP reading after
1st September 2015 in comparator patients). We did not
place any time restriction on the data other than the 1st
September 2015 cut-off, and so this method had the ad-
vantage of using all available surgery and telemonitoring
BP data. Surgery BP measurements from telemonitoring
patients were also included. The first telemonitored BP
value recorded for each patient was deleted in case this
had been used to test the system.
A random coefficients model was fitted to the BP out-
come data for each practice, and each model included
the following explanatory variables:
 Patient time indicating the number of weeks after
the first telemonitoring or surgery BP measurement
was recorded.
 Group indicator variable (0 = Surgery BP
measurements from surgery patients, 1 = Surgery BP
measurements from Telemonitoring patients, 2 =
Telemonitoring BP measurements).
 Patient time and group interaction term
 Random intercept term for patient
 Random effect for patient time (random slope)
 Number of BP measurements recorded in the year
prior to first measurement, as a categorical variable
(0, 1–4, 5 or more)
 Approximate patient age in 2015 (based on year of
birth), as a continuous linear term.
 Scottish Index of Multiple Deprivation (SIMD) of 5
or higher (yes or no)
 Sex (male or female)
Unstructured covariance was assumed.
In the model we considered within-patient time instead
of calendar time because we were primarily interested in
how BP changed over time within patients after they
started using telemonitoring rather than changes over
calendar time, which may have been confounded by
systematic differences in the recruited population over
time as practices rolled out the service.
Note that the “group indicator” main effect variable
adjusts for systematic differences in baseline systolic BP
and so this variable in theory should have taken full ac-
count of any potential ‘white coat effect’. The main focus
of the results was on the patient time and group inter-
action term since we were interested in how changes in
BP over time varied with treatment group.
The within-practice model results were then combined
in a random-effects meta-analysis using the DerSimonian-
Laird estimator. We used the “metafor” package [17] in R
software [18]. The rationale for using a random-effects
rather than a fixed-effect meta-analysis was that we were
interested in generalising the results to all 128 practices in
Lothian (not only the eight practices included in the
evaluation). An overall analysis including data from all
practices was possible, but at the cost of not being able to
adjust for practice. An overall model including both
practice and patient random-effects was fitted, but did not
converge. We think this was because the model was trying
to estimate a between-practice variability in outcome that
was effectively zero (or close to zero), and so an over-
all model without the practice random-effects seemed
reasonable.
Ethical considerations
This study was approved by the East of England–
Cambridge South Research Ethics Committee (16/EE/
0058). We made use of several routine electronic
health care data sources that were linked, de-identified,
and held in the NHS Research Scotland (NRS) Lothian
Research Safe Haven, only accessible by approved individ-
uals who had undertaken the necessary governance train-
ing. Patients participating in telemonitoring provided
individual written consent for their data to be analysed.
Anonymised data from comparator patients in the same
practices was unconsented. The local Caldecott Guardian
gave permission for the anonymised data to be analysed
within the NHS Safe Haven on the grounds of patient
benefit. It was only possible to export analysis results from




Figure 1 shows a summary flow diagram for the number
of observations and patients at each stage of the process-
ing procedure. In the raw telemonitoring dataset, there
were 64,029 telemonitored BP observations from 905
patients, but this was reduced to 63,840 observations
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after applying the exclusion criteria and deleting pre-
sumed erroneous observations. Restricting to BP read-
ings within 1 year of the index observation and patients
with a least a full year of follow-up, the number of ob-
servations was reduced to 39,286 observations from 430
patients. After further restriction to those patients with a
second Florence reading and another reading 6–12
months later, the number of patients reduced to 399.
In the raw database of comparator patients, there were
53,571 observations from 16,149 patients, and after ap-
plying the same exclusion criteria and restrictions as for
the telemonitoring group, this number was reduced to
20,415 observations from 7670 patients (see Fig. 1). After
further restriction involving deleting all patients under
18 or older than 90 years, and excluding any patients not
recording first and last BP more than 6 months apart,
the number of patients reduced to 3484.
End digit preference
A cross-tabulation of surgery measured systolic BP end
digits against diastolic BP end digits is shown in Table S1
in the supplementary file. We observed a very strong
double-zero preference in surgery-measured BP. The
percentage of BP readings with double zeros was 11%
(5877/54,073) which is much higher than the percentage
expected by chance of 1% and the percentage of 1.7%
(761/44,150) we observed in telemonitored BP readings
[10]. For systolic BP individually, Fig. 2 shows a markedly
higher percentage of BP readings ending with a zero, with
a similar pattern being observed for diastolic BP (see
Figure S1 in supplementary file). There is also a sugges-
tion of a preference for even end digits since all odd
digits are below the even digits in both bar charts.
Standardisation with stratification
Table 2 shows patient characteristics for those patients
in the telemonitoring and comparator groups who had
at least two BPs 6–12 months apart, and with at least 1
year of follow-up. The follow-up duration was restricted
to 12months for all patients.
Comparator patients were older on average, with a
slightly higher percentage of females, and lower SIMD
(i.e. more deprived). Index systolic BP readings were
similar.
Table 3 shows the percentage of patients with raised
systolic and diastolic BP at baseline and follow-up (final
reading 6–12months later) for the subgroup of patients
with valid BP values at both baseline and follow-up.
The observed improvements in BP control over time
were larger in the telemonitoring group. For example,
Fig. 1 Summary flow diagram of data processing procedure
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the percentage of patients with systolic BP of 145 mmHg
or above was 14% lower at 6–12months follow-up
compared to baseline (relative risk reduction of 60%
(95% CI 46 to 72)) for those in the telemonitoring group,
compared to only 7% lower for comparator group pa-
tients (relative risk reduction of 25% (95% CI 19 to 29)).
Therefore, the relative risk reduction in the telemonitor-
ing group was more than double what it was in the
comparator group (relative risk reduction ratio 2.43, 95%
CI 1.77 to 3.27). Even after taking into account ‘white
coat effect’ and comparing to those in the comparator
arm with systolic BP of 150 +mmHg, the relative risk
reduction was still greater in the telemonitoring arm
(relative risk reduction ratio 1.58, 95% CI 1.17 to 2.00).
Table 4 shows descriptive statistics for the change in
systolic BP (baseline – follow-up) for the telemonitoring
group, with similar changes for the comparator group in
brackets for comparison, stratified according to baseline
variables. Note that no adjustment for ‘white coat effect’
has been made to the data in this table. Stratifying the
results like this allowed us to see that the greatest
differences in BP change between telemonitoring and
comparator groups were for males, older patients (over
65 years), and those with relatively low systolic BP at
Fig. 2 End digits of surgery measured systolic BP in comparator patients
Table 2 Characteristics of patients in the telemonitoring and comparator groups, used for the stratification and matched analyses
Telemonitoring (n = 399) Comparator group (n = 3484)
Female sex 182/399 (46%) 1845/3484 (53%)
Age Mean 62.5 (SD 9.7) Mean 69.7 (SD 12.3)
Median 64 (IQR 56 to 70) Median 71 (IQR 62 to 79)
Range 29 to 89 Range 20 to 90
SIMD 2012 decile Mean 7.9 (SD 2.5) Mean 7.0 (SD 12.3)
Median 9 (IQR 6 to 10) Median 7 (IQR 5 to 10)
Range 2 to 10 Range 1 to 10
Index systolic BP readinga Mean 139.6 (SD 16.4) Mean 140.0 (SD 18.1)
Median 138 (IQR 128 to 150) Median 138 (IQR 130 to 150)
Range 100 to 188 Range 71 to 240
aIndex systolic BP values were unadjusted for white coat effect
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baseline, although there may have been some confound-
ing between each of these variables. A similar table for
diastolic BP differences is shown in the supplementary
file (Table S2).
We then fitted a linear mixed effects model in each
strata of systolic BP. The results for the group variable
(telemonitoring – comparator) are shown in Table S3.
Note that all of these results occurred after applying a −
5 ‘white coat effect’ adjustment.
The improvement in BP control was significantly
greater for telemonitoring patients compared to com-
parator patients for patients with systolic BP below 135
at baseline (4.06 (95% CI 1.82 to 6.30, p < 0.001), but no
significant difference was observed in the other categor-
ies (see Table S3). Telemonitoring appears to have a
protective effect against increased systolic BP over time
in those with already fairly low systolic BP at baseline.
Standardisation with matched cohort analysis
The mean difference in final systolic BP and diastolic BP
(Comparator patients – Telemonitoring patients) were
5.96 (95% CI 3.55 to 8.36, p < 0.001) and − 0.10 (95% CI
− 1.81 to 1.60, p = 0.904), respectively.
Therefore, the final systolic BP was lower for telemoni-
toring patients compared to comparator patients in
matched analysis after 6–12months, even after reducing
the systolic BP of comparator patients by a − 5 ‘white
coat effect’ adjustment.
We also performed detailed sensitivity analyses, adjust-
ing the matching criteria, and also the amount we
adjusted the surgery systolic BP readings (see Table 5).
The sensitivity analyses suggested that results were
quite sensitive to our assumption about the ‘white coat
effect’, although we note that reduction of the surgery
systolic BP readings had to be quite large to overturn
the result of a significant systolic BP difference in favour
of telemonitoring. If no ‘white coat effect’ adjustment
was made to diastolic BP, the mean difference was 3.07
(95% CI 1.43 to 4.71), which was also statistically signifi-
cant. The sensitivity analyses for diastolic BP are shown
in Table S4 in the Supplementary file.
Regression adjustment for propensity score
Final systolic BP was significantly lower in the telemoni-
toring group after adjusting for the propensity score and
assuming a − 5 adjustment for white coat effect (mean
Table 3 Percentage with raised SBP and DBP
Telemonitoring Comparator
Index reading 6–12months later Percentage Relative
Risk reduction
Index reading 6–12months later Percentage Relative
Risk reduction
SBP 135+ 190/399 (48%) 94/399 (24%) 51% 2119/3484 (61%) 1879/3484 (54%) 11%
SBP 140+ 138/399 (35%) 51/399 (13%) 63% 1658/3484 (48%) 1414/3484 (41%) 15%
SBP 145+ 92/399 (23%) 37/399 (9%) 60% 1132/3484 (32%) 854/3484 (25%) 25%
SBP 150+ 62/399 (16%) 20/399 (5%) 68% 894/3484 (26%) 555/3484 (16%) 38%
DBP 85+ 138/399 (35%) 66/399 (17%) 52% 1080/3484 (31%) 799/3484 (23%) 26%
DBP 90+ 90/399 (23%) 23/399 (6%) 74% 672/3484 (19%) 411/3484 (12%) 39%
SBP Systolic BP, DBP Diastolic BP
Table 4 Systolic BP differences in mmHg (baseline – final readings)
Stratification N Mean SD Median IQR Range
None (Overall) 399 [3484] 6.5 [3.5] 15.2 [19.5] 6 [2] −3 to 15 [− 8 to 14] − 37 to 63 [− 87 to 88]
Age < 65 211 [1049] 6.4 [4.5] 14.6 [19.0] 6 [4] − 3 to 16 [− 8 to 15] −28 to 55 [− 65 to 88]
Age 65+ 188 [2435] 6.7 [3.1] 15.8 [19.7] 6.5 [2] −3.5 to 13.5 [−9 to 14] − 37 to 63 [− 87 to 88]
Male 217 [1639] 6.9 [2.7] 15.2 [18.7] 7 [2] −3 to 15 [−9 to 14] − 37 to 63 [− 87 to 88]
Female 182 [1845] 6.1 [4.2] 15.2 [20.1] 5 [3] −3 to 15 [−8 to 15] − 34 to 53 [− 75 to 88]
SIMD < 5 (more deprived) 70 [811] 7.8 [4.1] 13.4 [19.2] 6.5 [3] 0 to 16 [−8 to 16] −25 to 50 [−55 to 88]
SIMD 5+ (more affluent) 329 [2673] 6.3 [3.3] 15.5 [19.5] 6 [2] −3 to 15 [−9 to 14] − 37 to 63 [−87 to 88]
Systolic BP < 135 209 [1365] −1.2 [−7.9] 11.8 [14.9] 0 [−7] − 7 to 7 [− 16 to 2] − 37 to 28 [− 72 to 44]
Systolic BP 135 or above 190 [2119] 15.1 [10.8] 13.9 [18.5] 13 [9] 6 to 23 [0 to 21] −17 to 63 [−87 to 88]
Systolic BP 140 or above 138 [1658] 17.7 [13.6] 14.0 [18.8] 16.5 [12] 9 to 25 [2 to 24] −17 to 63 [−75 to 88]
Systolic BP 145 or above 92 [1132] 20.9 [18.3] 14.0 [18.9] 21 [18] 11 to 27.5 [7 to 29] −17 to 63 [−75 to 88]
Systolic BP 150 or above 62 [894] 23.8 [21.4] 14.8 [18.8] 22.5 [21] 12 to 34 [10 to 32] −10 to 63 [−75 to 88]
Numbers are shown as Telemonitoring [Comparator]
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difference − 3.73, 95% CI − 5.34 to − 2.13, p < 0.0001).
This difference remained, even after applying a − 7
adjustment (mean difference − 2.19, 95% CI − 3.80 to
− 0.58, p = 0.01).
Random coefficients model analysis
The random coefficients model analysis had the advan-
tage of using all the BP outcome data for patients as well
as being able to take into account the time of measure-
ments after each patient first started using telemonitor-
ing (or first started recording readings after September
2015 in the comparator group). Table 6 shows the
patient characteristics of this sample.
As Table 2 showed, comparator patients were older on
average, with a slightly higher percentage of females, and
lower SIMD. Interestingly, unlike in Table 2 which
showed no clear difference, baseline systolic BP was
higher among the comparator patients on average com-
pared to the telemonitoring group.
Figure 3 shows the mean differences of systolic BP
change per week (with 95% confidence intervals) for tel-
emonitored BP in telemonitoring patients versus surgery
measured BP in comparator patients in each practice,
with a summary effect size computed using random ef-
fects meta-analysis.
Systolic BP change over time was significantly higher
in the telemonitored group. The weekly improvement
under telemonitoring was estimated to be − 0.06 (95%
CI − 0.10 to − 0.03) or − 3.37 (95% CI − 5.41 to − 1.33)
per year. The overall analysis across all sites, unadjusted
for site, gave a very similar result of − 0.06 (95% CI −
0.08 to − 0.04) or − 3.19 (− 4.16 to − 2.23) per year, albeit
more precise.
Note that by means of the group main effect term in
the random coefficients model this analysis adjusts for
‘white coat effect’, provided that the magnitude of this
potential bias remained constant over time, which is a
plausible assumption.
The figures show high variation in results across prac-
tices with a few practices (especially small practices)
showing large effects of telemonitoring.
Figure S2 in the supplementary file shows a similar
plot for change in diastolic BP.
Additionally, Figures S3 and S4 show forest plots for
the comparison of surgery measured BP between tele-
monitoring and comparator patients for systolic and






Mean difference 95% confidence interval P-value
1 Nearest SBP with end digit 0 or 5 0 212 7.11 5.03 to 9.19 < 0.001
2 Nearest SBP with end digit 0 or 5 −7 201 4.01 1.47 to 6.56 0.002
3 Nearest SBP with end digit 0 or 5 −10 211 1.83 −0.55 to 4.21 0.131
4 Exact SBP matching 0 119 5.70 2.78 to 8.61 < 0.001
5 Exact SBP matching −5 120 5.67 2.24 to 9.09 0.001
6 Exact SBP matching −7 128 2.25 −0.67 to 5.17 0.130
7 Exact SBP matching −10 123 2.23 −0.74 to 5.19 0.140
8 Nearest SBP with end digit 0 −5 208 3.90 1.39 to 6.42 0.003
9 Nearest SBP with end digit 0 −7 209 2.90 0.53 to 5.28 0.017
aAdjustment was applied to matching values as well as final values
Table 6 Patient characteristics of all patients in the telemonitoring and comparator groups
Telemonitoring (n = 882) Comparator group (n = 7806)
Female sex 413/882 (47%) 4115/7806 (53%)
Age Mean 62.5 (SD 10.2) Mean 68.7 (SD 12.7)
Median 64 (IQR 56 to 70) Median 70 (IQR 60 to 79)
Range 22 to 89 Range 19 to 90
SIMD 2012 decile Mean 7.7 (SD 2.5) Mean 7.0 (SD 2.5)
Median 8 (IQR 6 to 10) Median 7 (IQR 5 to 10)
Range 2 to 10 Range 1 to 10
Index systolic BP reading Mean 134.4 (SD 16.4) Mean 140.1 (SD 18.2)
Median 134 (IQR 124 to 144) Median 139 (IQR 129 to 150)
Range 90 to 205 Range 71 to 240
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diastolic BP respectively, but due to widespread entry of
telemonitored readings into GP surgery systems these
results should be interpreted with caution.
Overall assessment of analyses
In Table 7, we consider how well all of the analyses
address the biases outlined in the Introduction section.
All analyses were conducted using SAS software version
9.4 (SAS Institute Inc., Cary, NC, USA) except where
indicated above.
Discussion
This implementation study provides further supportive
evidence to suggest that improved BP control due to
telemonitoring seen in previous RCTs is also present
when rolling out telemonitoring in the community. We
previously reported a reduction in systolic BP over time
for telemonitoring patients, but a key limitation was that
it may have been affected by regression to the mean [6].
This study is therefore a step forward because it
compares the telemonitoring BPs to a contemporaneous
comparator group. However, although we adjusted for
key variables at baseline, at the analysis stage we could
not completely exclude residual differences between the
cohorts at baseline. We also faced a number of other
challenges described in this paper such as substantial
differences in the frequency of BP readings between
cohorts, unrepresentative surgery measured BPs (e.g.
due to ‘white coat effect’), differential levels of end digit
preference, and erroneous or missing data. End digit
preference in particular was higher in the comparator
group compared to the telemonitoring group. The
percentage of BP readings with double zeros was 11%;
which although higher than the 1.7% we observed for
telemonitored readings in our previous study [10], was
still lower than what was found in a recent study by
Greiver et al. [11], which suggested a value of approxi-
mately 17% [11]. This could indicate greater use of auto-
mated sphygmomanometers in the participating GP
surgeries [11] or greater use of self-purchased home
monitors by some patients in the comparator group
(assuming home readings were then transcribed by GPs).
Many of the challenges and potential biases we have
encountered will also be relevant for other studies using
routinely acquired data. Indeed, some of these challenges
have already been reported in other studies [1, 19].
The random coefficients model analysis had the ad-
vantage of using all the data, and of the four methods
Summary estimate
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Telemonitored BP minus surgery BP from comparator patients
Fig. 3 Forest plot showing between-group differences in change of systolic BP for telemonitored BP – surgery measured BP in comparator patients
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was thought to have controlled best for the ‘white coat
effect’. The other methods relied on assumptions about
the degree of ‘white coat effect’ that may not have been
true. However, the random coefficients analysis was still
susceptible to residual confounding and changes in the
level of biases over time (including changes in ‘white
coat effect’). Differences in the frequency of readings
between groups may also have caused an issue due to
missing data bias. The random coefficient models as-
sumed a linear change in BP over time, which increased
interpretability of the results and appeared to be sup-
ported by line plots over 12 months, but this was still an
assumption that may have masked underlying non-
linearity in changes over time. Adjustment of potential
confounders may also have been improved by fitting
splines; but we did not do this due to the risk of conver-
gence failure. Indeed, we experienced problems fitting
random-effects for both practice and patient. The
models did not converge, which may have been because
the between practice effect was close to zero. Fitting
separate per practice models and then combining in a
random effects meta-analysis helped us to circumvent
the problem of the model failing to converge when the
practice variable was in the model. The forest plots also
Table 7 Assessment of how well the analyses control for key potential biases
Challenges Ability of the models to control for bias
(1) Non-randomised design Limited. Stratification helps to some extent to control confounding, but covariate adjustment in linear mixed
effects models provides better adjustment. There still may have been residual confounders.
For the matched cohort analysis, there was excellent control of confounding due to matching, but there still
may have been residual confounding by underlying variables not used to match on.
(2) White coat effect Depends on the validity of the assumption for the difference due to ‘white coat effect’.
Matched cohort analysis results were found to be fairly sensitive to this assumption.
In the random coefficients model, this was fully adjusted by means of adjusting for intervention/control group
at baseline, although we make the reasonable assumption that the degree of ‘white coat effect’ did not
change over time.
(3) High variability in the frequency
of readings
Partially. Standardisation meant that frequencies of readings were the same between groups, but subgroup
selection to achieve this may have resulted in a biased subgroup. Regression adjustment for propensity score
or matching may have only partially addressed this bias by controlling for confounders between groups.
Mixed effects models make a missing-at-random assumption for missing data. If this assumption holds true in
estimating the change in BP over time, then the difference in frequency of readings would have had no effect
on the estimated treatment effect because the change in BP would be correctly modelled in each group.
However, if the reason for missing data (or different frequencies) was more or less informative in one of the
groups compared to the other however (e.g. indicating low BP in comparator patients) then this could have
biased the results.
(4) Contamination of readings Not an issue. All methods compared telemonitored BP with surgery measured BP from comparator patients.
(5) Regression to the mean At least partially. Will be controlled to some extent due to comparison with comparator group and matching,
but there may be differences in the strength of regression-to-the-mean between treatment and comparator
groups. For example, it is conceivable that between-group differences in the inclusion probabilities for patients
with greater propensity for stronger regression-to-the mean (e.g. those with intermittently high or unstable BP),
might contribute to confounding bias.
(6) Measurement error This was not addressed by any of the analysis methods based on the standardised data. We expect that there
might have been attenuation of the intervention effect towards zero as a result. The random coefficients
model did not fully address this, although the model did include all of the multiple BP measurements per
patient which would have improved estimation of within-patient variability and the underlying true change in
BP within each patient.
(7) End digit preference End digit preference will compound the effect of any measurement error such that it will lead to observed
values deviating from their true values. The analyses were limited in their ability to deal with end digit
preference in the same way as for measurement error.
If there was differential change in end digit preference or specific value preference over time in one group
compared to the other, then it may have caused confounding bias. For the matched analysis, patients may
not have been matched correctly by systolic BP due to differential end digit bias between groups. Again, we
were reliant on the reliability of the assumption about the true BP in each group. Adjustment for group at
baseline in a random coefficient model should in theory have adjusted for differences in the strength of digit
preference.
(8) Withdrawal bias For the analyses based on the standardised dataset we used subgroup selection to select out everyone with at
least two readings at baseline and follow-up. Patients who withdrew from the telemonitoring arm or those in
the comparator arm who got their BP measured less frequently were more likely to be excluded from the
analysis, and so this problem reduces to the problem of incomparable groups and residual confounding
(issue (1)).
For the random coefficient model analysis, this analysis assumes any missing data is “missing-at-random”
conditional on covariates used in the adjustment. If the reasons for missing data or missing data mechanisms
differed according to treatment group, and these were not taken into account in the statistical model, then this
may have biased the results.
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allowed us to compare results across the different
practices. Indeed, it was interesting to observe substan-
tial variation across practices, with some small practices
showing strong telemonitoring effects. This is not
surprising given that practices had different policies for
introducing the telemonitoring, with some focussing on
uncontrolled patients while others on well controlled.
Matched cohort studies are a useful way to eliminate
known confounders [20]. In this study, we matched on
(i) exact SIMD, (ii) gender, (iii) age in decades (e.g. 50,
60), and (iv) index systolic BP to the nearest value end-
ing in 0 or 5. After matching we used a paired t-test for
analysis rather than a linear mixed regression model
adjusting for the matching variables to maximise the
precision of estimation. This is a valid approach since
we did not adjust for additional confounders; but, as for
the other analyses, this approach also assumes that there
were no additional confounders or other sources of bias
[21]. Although this analysis provided the greatest control
over baseline covariates through matching, the sample
size of available matched pairs was fairly small and many
sensitivity analyses were required. Propensity score
matching was an alternative method which may have
improved the numbers of matched pairs. This analysis
method has been widely used in practice over the last
30 years to control for selection bias in observational
studies [22]. An advantage of the method is that it only
requires matching on a single variable (the propensity
score), rather than matching on multiple covariates, and
so is easier to use [22]. Indeed, it is particularly useful if
the number of covariates available for matching is large
[22]. Although this approach has received some criticism
in recent years, it is an appropriate method if used with
care [22, 23]. In particular, there is a need to check the
balance of key prognostic factors across intervention/
control groups after matching [22].
We applied a different propensity score method in-
volving “regression adjustment for propensity score”,
recognising the advantage that propensity score methods
have in terms of being able to summarise a long list of
confounders into a single score [16]. In our case, we only
had routinely collected data on a few confounders so
this advantage could not be fully realised. Nevertheless,
the method enabled unbiased estimation of treatment
effect even in the case of an incorrectly specified out-
come regression model, provided that the propensity
score model was correctly specified [16]. In addition, the
method allowed us to make use of all data available from
the standardized dataset, unlike the matched cohort
analysis.
The “standardisation with stratification” method had
the advantage of highlighting subgroups in which the
between group differences were greatest. The results
suggested that older patients or those with lower levels
of hypertension showed particular benefit from using
telemonitoring, implying that telemonitoring systems
should not only be restricted to younger patients (who
might be perceived to be more technically literate) or
those with very high levels of hypertension, but should
be offered widely to those on the hypertension register.
Indeed this finding provides some evidence for persistent
BP monitoring rather than just titration to control and
stopping.
A strength of this study was that four different statis-
tical methods were used to analyse the data and reached
similar conclusions, although none of the methods could
completely exclude the possibility of residual confound-
ing and all methods were susceptible to changes in
certain biases over time (e.g. level of ‘white coat effect’,
transcription of home readings into GP practice systems,
and differential changes in end digit preference). For
studies involving routinely acquired data in general, it is
important that researchers are aware of these potential
biases and consider in advance how their statistical ana-
lyses will address these. Applying multiple statistical
methods to the same problem gives reassurance that any
results observed are not dependent on the statistical
method, although as we have seen there may be some
overlap in their methodological limitations.
A limitation of all our analyses was that we did not
take into account potential measurement error in the
blood pressure outcomes. Instead of using single mea-
surements at baseline and 6–12months later, we could
have calculated the average of three (or more) readings
at baseline and 6–12months which would have reduced
within-patient variability. However, this would have sub-
stantially reduced the overall sample size for all of the
analyses because many patients recorded fewer than
three readings at baseline and 6–12 months later. The
impact of any measurement error and/or end digit
rounding bias is expected to attenuate the intervention
effect towards zero. The fact that we observed a telemo-
nitoring effect across all methods despite the possibility
of measurement error bias or end digit bias, only serves
to strengthen our conclusion of a real telemonitoring
effect.
We also recognise that comparing the random coeffi-
cient analysis method against the other methods was not
really a fair comparison in some respects because this
method was the only method that utilised all of the
available data. However, we believe that precisely be-
cause of this reason, the random coefficient analysis
should be recommended above others in this context,
due to its potential to give more representative and
generalizable results in this pragmatic study. Although
the other analyses based on the standardized dataset
may have ensured that the telemonitoring/control
groups were more consistent in terms of their frequency
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of BP measurement, these analyses may still have been
affected by residual selection bias. For the random coef-
ficients analysis, there was a large sample size available
of over 7500, with only a few confounders available to
adjust for. In other settings with smaller sample size and
a greater number of confounders, it may be more advan-
tageous to adjust for the propensity score in the random
coefficients analysis to increase statistical power, espe-
cially if there is missing data on some covariates.
This was a real world roll-out of a telehealth interven-
tion which had the advantage that patients did not need
to sign up to the research or attend clinic visits for data
collections. Other designs (especially novel randomised
trials) may have provided better control of biases, but
they were likely to have been less pragmatic or achiev-
able in this setting and the trial processes may have led
to reduced external validity. A cluster randomised trial
design was explored as a potential study design, although
for clinically relevant “hard” outcomes such as stroke or
ischaemic heart disease, these outcomes are rare and so
the sample size requirement was extremely high. For ex-
ample, we previously calculated we would need 25,643
patients per group (51,286 in total), in order to detect a
relative risk reduction of 15% with 90% power, assuming
a two-sided 5% significance level; and that is even before
applying an inflation factor to take into account poten-
tial withdrawals or to allow for clustering by practice.
Note also, that many of the biases may still have been
present even in a randomised design (e.g. differential
changes in end digit preference). Finally, we acknow-
ledge that the duration of follow-up for many of our pa-
tients was short (up to 12months). Longer term studies
are appropriate to investigate if the telemonitoring effect
continues or wanes over time.
Studies of telehealth interventions face the same trade-
off between internal and external validity as studies of
digital health interventions more generally [24, 25]. That
is, studies with high internal validity such as randomized
controlled trials of telemonitoring are likely to have
limited external validity due to rigorous trial procedures,
increased face-to-face contact between research staff and
participants, and by inclusion of a motivated consent-to-
trial population [25]. Indeed, there is often a danger that
randomised trial processes constitute an intervention in
their own right and thereby increase adherence and
patient motivation [26]. On the other hand, non-
randomised implementation studies are better for inform-
ing public policy due to improved external validity and
generalisability, but with the greater potential for various
biases affecting the results. We therefore recommend that
both types of studies are conducted to provide a wide-
ranging evidence base, but the challenge is to develop
statistical methods capable of addressing the complex
array of biases that may be present in implementation
studies, particularly in those involving routinely acquired
data. As always, the context of study is crucial. Not all of
the biases we have listed in this article will be relevant for
every implementation study; even in those studies
comparing BP using routinely acquired data. However, we
hope that the list of biases we have provided can help as a
useful starting point in implementation studies involving
routinely acquired data. At the design stage, we recom-
mend that researchers collect data on as many potential
confounders as possible prior to analysis and adjust for
them in the analysis model either individually or via
propensity score. Researchers should be wary of how any
biases will influence the analysis results and adjust the
strength of their conclusions accordingly.
Conclusions
In conclusion, our study provides additional evidence of
the effectiveness of telemonitoring, and suggests that
initiatives to roll out telemonitoring at scale should be
encouraged. Future implementation studies are needed
to confirm the findings of our study, particularly those
enabling longer-term follow-up. Routine data give us the
opportunity to monitor if expected improvements in
outcome occur, but appreciation of potential biases and
careful development of analytical methods is important
to ensure that the findings are reliable. The random
coefficient analysis is particularly recommended in this
setting due to its ability to utilise all available data and
take into account multiple repeated measurements per
patient.
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